Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors

Am J Med. 2001 Feb 19:110 Suppl 3A:33S-42S. doi: 10.1016/s0002-9343(00)00699-9.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Comorbidity
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Hemodynamics / drug effects
  • Homeostasis / drug effects
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Kidney Diseases / chemically induced*
  • Membrane Proteins
  • Middle Aged
  • Prostaglandin-Endoperoxide Synthases
  • Prostaglandins / physiology
  • Renal Circulation / drug effects
  • Risk Factors
  • Safety

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Prostaglandins
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases